Tom Rozema

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 16, 2026

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Journal: PloS one

Published: January 12, 2026

Health-related quality of life after definitive chemoradiotherapy in patients with esophageal carcinoma: a population-based analysis.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 05, 2025

Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.

Journal: JAMA oncology

Published: December 21, 2023

Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates.

Journal: International journal of radiation oncology, biology, physics

Published: December 23, 2022

Patient- and physician-reported radiation-induced toxicity of short-course radiotherapy with a prolonged interval to surgery for rectal cancer.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: June 14, 2022

Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients.

Journal: Clinical and translational radiation oncology

Published: December 27, 2021

Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.

Journal: BMC health services research

Published: November 01, 2021

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 08, 2021

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 23, 2021

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Ultra-hypofractionated versus conventional chemoradiation for newly diagnosed glioblastoma: Survival and toxicity results of a multicenter randomized trial.

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG).

Health-related quality of life after definitive chemoradiotherapy in patients with esophageal carcinoma: a population-based analysis.

Health-related quality of life after definitive chemoradiotherapy in patients with esophageal carcinoma: a population-based analysis.

Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.

Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes.

Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates.

Coverage of Lateral Lymph Nodes in Rectal Cancer Patients with Routine Radiation Therapy Practice and Associated Locoregional Recurrence Rates.

Patient- and physician-reported radiation-induced toxicity of short-course radiotherapy with a prolonged interval to surgery for rectal cancer.

Patient- and physician-reported radiation-induced toxicity of short-course radiotherapy with a prolonged interval to surgery for rectal cancer.

Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients.

Pre-treatment visualization of predicted radiation-induced acute alopecia in brain tumour patients.

Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.

Clinical variation in the organization of clinical pathways in esophagogastric cancer, a mixed method multiple case study.

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study).

Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study).

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial.

Deciphering the glioblastoma phenotype by computed tomography radiomics.

Deciphering the glioblastoma phenotype by computed tomography radiomics.

Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.

Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.